Mucormycosis: What emergency physicians need to know?

Brit Long, Alex Koyfman

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations


Background Mucormycosis is a rare presentation for patients in the emergency department (ED), primarily affecting immunocompromised patients. Multiple forms of infection are present, and with poor prognosis, ED diagnosis and treatment of this deadly condition are necessary. Objective of review The aim of this review is to provide an overview of the presentations and forms of mucormycosis, diagnosis, and treatment of this deadly disease. Discussion This review provides background on the fungi causing mucormycosis, which are prevalent in nature. The article discusses the risk factors for infection with mucormycosis, as normal hosts are able to clear the disease, but immunocompromised and diabetic patients are at risk for organism inoculation and spread. The fungi are angioinvasive and cause necrosis. This article describes the various forms of the disease: rhino-orbital-cerebral, pulmonary, central nervous system, gastrointestinal, renal, disseminated, and cutaneous. Finally, this review evaluates diagnosis, treatment, and prognosis. Conclusion Emergency department diagnosis and treatment are necessary in patients with infection with mucormycosis. Physicians should be suspicious of this disease in immunocompromised and diabetic patients. Treatment requires antifungal agents such as amphotericin B and surgical debridement. Prognosis is poor.

Original languageEnglish (US)
Pages (from-to)1823-1825
Number of pages3
JournalAmerican Journal of Emergency Medicine
Issue number12
StatePublished - 2015

ASJC Scopus subject areas

  • Emergency Medicine


Dive into the research topics of 'Mucormycosis: What emergency physicians need to know?'. Together they form a unique fingerprint.

Cite this